These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 19643913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.
    Ford BE, Chachra SS, Rodgers K, Moonira T, Al-Oanzi ZH, Anstee QM, Reeves HL, Schattenberg JM, Fairclough RJ, Smith DM, Tiniakos D, Agius L.
    Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802
    [Abstract] [Full Text] [Related]

  • 4. Kinetic Basis of Carbohydrate-Mediated Inhibition of Human Glucokinase by the Glucokinase Regulatory Protein.
    Casey AK, Miller BG.
    Biochemistry; 2016 May 31; 55(21):2899-902. PubMed ID: 27174229
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study.
    Wang K, Shi M, Luk AOY, Kong APS, Ma RCW, Li C, Chen L, Chow E, Chan JCN.
    Cardiovasc Diabetol; 2024 Jun 29; 23(1):228. PubMed ID: 38951793
    [Abstract] [Full Text] [Related]

  • 9. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency.
    Buziau AM, Oosterveer MH, Wouters K, Bos T, Tolan DR, Agius L, Ford BE, Cassiman D, Stehouwer CDA, Schalkwijk CG, Brouwers MCGJ.
    Mol Metab; 2024 Sep 29; 87():101984. PubMed ID: 38972375
    [Abstract] [Full Text] [Related]

  • 10. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM, Galán M, Vincent O, Flández B, Gargallo M, Delgado-Alvarez E, Blázquez E, Navas MA.
    Diabetologia; 2007 Feb 29; 50(2):325-33. PubMed ID: 17186219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants.
    Ford BE, Chachra SS, Alshawi A, Oakley F, Fairclough RJ, Smith DM, Tiniakos D, Agius L.
    Biochem Pharmacol; 2024 Nov 29; 229():116499. PubMed ID: 39173844
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural basis for regulation of human glucokinase by glucokinase regulatory protein.
    Beck T, Miller BG.
    Biochemistry; 2013 Sep 10; 52(36):6232-9. PubMed ID: 23957911
    [Abstract] [Full Text] [Related]

  • 15. Antidiabetic Disruptors of the Glucokinase-Glucokinase Regulatory Protein Complex Reorganize a Coulombic Interface.
    Martinez JA, Xiao Q, Zakarian A, Miller BG.
    Biochemistry; 2017 Jun 20; 56(24):3150-3157. PubMed ID: 28516783
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.
    Raimondo A, Rees MG, Gloyn AL.
    Curr Opin Lipidol; 2015 Apr 20; 26(2):88-95. PubMed ID: 25692341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.